Medicenna Therapeutics Corp. (TSX:MDNA)
Canada
· Delayed Price · Currency is CAD 0.860
+0.040 (4.88%)
Mar 9, 2026, 3:59 PM EST
Medicenna Therapeutics Balance Sheet
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 10.61 | 24.84 | 16.98 | 33.6 | 20.54 | 30.38 | Upgrade
|
| Trading Asset Securities | - | - | - | - | - | 10.01 | Upgrade
|
| Cash & Short-Term Investments | 10.61 | 24.84 | 16.98 | 33.6 | 20.54 | 40.39 | Upgrade
|
| Cash Growth | -64.61% | 46.26% | -49.45% | 63.60% | -49.15% | 7.12% | Upgrade
|
| Other Receivables | 1.47 | 2.7 | 1.16 | 0.86 | 1.31 | 0.41 | Upgrade
|
| Receivables | 1.47 | 2.7 | 1.16 | 0.86 | 1.31 | 0.41 | Upgrade
|
| Prepaid Expenses | 0.84 | 0.64 | 0.93 | 1.93 | 1.55 | 1.35 | Upgrade
|
| Total Current Assets | 12.91 | 28.17 | 19.08 | 36.39 | 23.39 | 42.15 | Upgrade
|
| Property, Plant & Equipment | 0.1 | 0.16 | - | - | - | 0.03 | Upgrade
|
| Other Intangible Assets | 0.05 | 0.05 | 0.06 | 0.06 | 0.07 | 0.07 | Upgrade
|
| Total Assets | 13.07 | 28.38 | 19.13 | 36.45 | 23.46 | 42.25 | Upgrade
|
| Accounts Payable | 4.25 | 2.7 | 2.07 | 1.62 | 1.67 | 2.25 | Upgrade
|
| Accrued Expenses | 0.51 | 1.69 | 0.79 | 2.18 | 0.95 | 1.83 | Upgrade
|
| Current Portion of Leases | 0.07 | 0.05 | - | - | - | 0.03 | Upgrade
|
| Other Current Liabilities | - | - | - | 3.16 | - | - | Upgrade
|
| Total Current Liabilities | 4.82 | 4.44 | 2.86 | 6.96 | 2.62 | 4.11 | Upgrade
|
| Long-Term Leases | 0.07 | 0.12 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 1.96 | 4.73 | 11.08 | - | - | - | Upgrade
|
| Total Liabilities | 6.85 | 9.29 | 13.94 | 6.96 | 2.62 | 4.11 | Upgrade
|
| Common Stock | 126.26 | 116.3 | 100.92 | 100.92 | 83.67 | 79.59 | Upgrade
|
| Additional Paid-In Capital | 12.33 | 11.22 | 10.7 | 9.49 | 7.93 | 6.68 | Upgrade
|
| Retained Earnings | -132.43 | -118.25 | -106.45 | -80.98 | -70.93 | -48.36 | Upgrade
|
| Comprehensive Income & Other | 0.05 | 9.83 | 0.02 | 0.06 | 0.17 | 0.23 | Upgrade
|
| Total Common Equity | 6.21 | 19.1 | 5.19 | 29.49 | 20.84 | 38.15 | Upgrade
|
| Shareholders' Equity | 6.21 | 19.1 | 5.19 | 29.49 | 20.84 | 38.15 | Upgrade
|
| Total Liabilities & Equity | 13.07 | 28.38 | 19.13 | 36.45 | 23.46 | 42.25 | Upgrade
|
| Total Debt | 0.14 | 0.17 | - | - | - | 0.03 | Upgrade
|
| Net Cash (Debt) | 10.48 | 24.67 | 16.98 | 33.6 | 20.54 | 40.35 | Upgrade
|
| Net Cash Growth | -64.86% | 45.27% | -49.45% | 63.60% | -49.11% | 7.22% | Upgrade
|
| Net Cash Per Share | 0.13 | 0.32 | 0.24 | 0.52 | 0.38 | 0.81 | Upgrade
|
| Filing Date Shares Outstanding | 83.42 | 83.38 | 76.18 | 69.64 | 56.3 | 53.55 | Upgrade
|
| Total Common Shares Outstanding | 83.42 | 78.22 | 69.64 | 69.64 | 55.65 | 53.55 | Upgrade
|
| Working Capital | 8.09 | 23.74 | 16.21 | 29.43 | 20.77 | 38.04 | Upgrade
|
| Book Value Per Share | 0.07 | 0.24 | 0.07 | 0.42 | 0.37 | 0.71 | Upgrade
|
| Tangible Book Value | 6.16 | 19.04 | 5.13 | 29.43 | 20.77 | 38.07 | Upgrade
|
| Tangible Book Value Per Share | 0.07 | 0.24 | 0.07 | 0.42 | 0.37 | 0.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.